CME: To Be or Not to Be

  • by: |
  • 07/06/2010
Physician and health policy blogger Kevin Pho ponders the consequences of a full-fledged ban on industry sponsorship of continuing medical eduction (CME).
 
Dr. Pho writes:
 
Whatever the case, if the industry doesn’t support CME, doctors and medical schools are going to have to pay for it. That means higher course fees for doctors — which will hurt physicians who do not have a CME-allotment as part of their benefits.

Medical societies also won’t be happy, as their conferences will be more expensive to run.

There has to be a solution short of a total ban, because with the CME industry a billion dollar business, there’s simply too much money at stake.

But one of the physician comments to Dr. Pho’s blog caught my eye:
 
OK let me be the Devil’s Advocate here … we NEED money to produce CME courses – annual meetings, etc. Where are those dollars coming from? Moreover, isn’t it a bit hypocritical that folks in Congress who take far more Lobbyist money than any physicians’ group should complain about industry sponsorship of cme. No, the government will mandate cme, prohibit industry sponsorship, and force yet another Unfunded Mandate down our throats. And you can pry that Viagra pen from my cold dead hand.
 
How right he is. The move to limit (or outright ban) industry-sponsored CME is not only grossly misguided, it is hypocrisy at its worst.
 
Some of the foremost proponents of a ban interestingly have no qualms about accepting support from the industry, trial lawyer lobby, etc.
 
This campaign is simply one aspect of the continuing assault on our nation’s doctors.

CMPI

Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
AHRP
Better Health
BigGovHealth
Biotech Blog
BrandweekNRX
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
CNEhealth.org
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
eDrugSearch
Envisioning 2.0
EyeOnFDA
FDA Law Blog
Fierce Pharma
fightingdiseases.org
Fresh Air Fund
Furious Seasons
Gooznews
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
IgniteBlog
In the Pipeline
In Vivo
Instapundit
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
KevinMD
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
Medrants
More than Medicine
National Review
Neuroethics & Law
Newsbusters
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
PAL
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmablogger
Pharmacology Corner
Pharmagossip
Pharmamotion
Pharmalot
Pharmaceutical Business Review
Piper Report
Polipundit
Powerline
Prescription for a Cure
Public Plan Facts
Quackwatch
Real Clear Politics
Remedyhealthcare
Shark Report
Shearlings Got Plowed
StateHouseCall.org
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
TortsProf
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog